He, T.;                     Wang, M.;                     Mi, H.;                     Xu, L.;                     Lu, W.;                     Ouyang, X.;                     Guo, Z.;                     Su, C.    
        Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study. Vaccines 2023, 11, 532.
    https://doi.org/10.3390/vaccines11030532
    AMA Style
    
                                He T,                                 Wang M,                                 Mi H,                                 Xu L,                                 Lu W,                                 Ouyang X,                                 Guo Z,                                 Su C.        
                Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study. Vaccines. 2023; 11(3):532.
        https://doi.org/10.3390/vaccines11030532
    
    Chicago/Turabian Style
    
                                He, Tingjuan,                                 Meixia Wang,                                 Hongfei Mi,                                 Liansheng Xu,                                 Wenkui Lu,                                 Xue Ouyang,                                 Zhinan Guo,                                 and Chenghao Su.        
                2023. "Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study" Vaccines 11, no. 3: 532.
        https://doi.org/10.3390/vaccines11030532
    
    APA Style
    
                                He, T.,                                 Wang, M.,                                 Mi, H.,                                 Xu, L.,                                 Lu, W.,                                 Ouyang, X.,                                 Guo, Z.,                                 & Su, C.        
        
        (2023). Effectiveness of Inactivated Vaccine against SARS-CoV-2 Delta Variant Infection in Xiamen, China—A Test-Negative Case-Control Study. Vaccines, 11(3), 532.
        https://doi.org/10.3390/vaccines11030532